Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Advances in Cancer Research|October 11, 2002
A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistanceChuen-Pei Ng, Benjamin Bonavida
Critical Reviews in Oncogenesis|June 25, 2025
Preface: Probiotics and Implications in OncogenesisBenjamin Bonavida, Luca Falzone, Massimo Libra
International Journal of Oncology|October 25, 2008
Nitric oxide donors: novel cancer therapeutics (review)Sergio Huerta, Sapna Chilka, Benjamin Bonavida
Cells|February 26, 2026
The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune EvasionAnia Khachikian, Mai Ho, Benjamin Bonavida
Genes & Cancer|August 16, 2018
Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironmentSusan Bae, Jeffrey Brumbaugh, Benjamin Bonavida
Critical Reviews in Oncogenesis|April 2, 2018
The Forgotten YY2 in Reported YY1 Expression Levels in Human CancersSamantha Kaufhold, Nabil Aziz, Benjamin Bonavida
Current Pharmaceutical Design|March 12, 2009
Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQAlina Katsman, Kazuo Umezawa, Benjamin Bonavida
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 20, 2007
Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agentAlina Katsman, Kazuo Umezawa, Benjamin Bonavida
International Journal of Oncology|January 6, 2012
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancerYoichi Mizutani, Yoji Katsuoka, Benjamin Bonavida
Critical Reviews in Oncogenesis|April 5, 2022
Cross Talk between the Circadian Clock Proteins and TP53 in Cancer and Therapeutic SignificanceBrandon Valafar, Apostolos Zaravinos, Benjamin Bonavida
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Advances in Cancer Research|October 11, 2002
A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistanceChuen-Pei Ng, Benjamin Bonavida
Critical Reviews in Oncogenesis|June 25, 2025
Preface: Probiotics and Implications in OncogenesisBenjamin Bonavida, Luca Falzone, Massimo Libra
International Journal of Oncology|October 25, 2008
Nitric oxide donors: novel cancer therapeutics (review)Sergio Huerta, Sapna Chilka, Benjamin Bonavida
Cells|February 26, 2026
The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune EvasionAnia Khachikian, Mai Ho, Benjamin Bonavida
Genes & Cancer|August 16, 2018
Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironmentSusan Bae, Jeffrey Brumbaugh, Benjamin Bonavida
Critical Reviews in Oncogenesis|April 2, 2018
The Forgotten YY2 in Reported YY1 Expression Levels in Human CancersSamantha Kaufhold, Nabil Aziz, Benjamin Bonavida
Current Pharmaceutical Design|March 12, 2009
Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQAlina Katsman, Kazuo Umezawa, Benjamin Bonavida
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 20, 2007
Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agentAlina Katsman, Kazuo Umezawa, Benjamin Bonavida
International Journal of Oncology|January 6, 2012
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancerYoichi Mizutani, Yoji Katsuoka, Benjamin Bonavida
Critical Reviews in Oncogenesis|April 5, 2022
Cross Talk between the Circadian Clock Proteins and TP53 in Cancer and Therapeutic SignificanceBrandon Valafar, Apostolos Zaravinos, Benjamin Bonavida
Pageof 20